StemCell Institute Inc. (TYO:7096)

Market Cap	8.49B
Revenue (ttm)	2.72B
Net Income (ttm)	198.00M
Shares Out	10.25M
EPS (ttm)	19.45
PE Ratio	42.63
Forward PE	52.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,300
Average Volume	29,475
Open	817.00
Previous Close	833.00
Day's Range	817.00 - 841.00
52-Week Range	744.00 - 1,543.00
Beta	0.53
RSI	66.55
Earnings Date	Feb 12, 2026

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of new cell-based treatments, and pharmaceuticals and medical devices. It also engages in cell contract management and transportation business; extraction, purification, processing, storage, testing and sales of biological tissue-derived components; and medical facility operation and management business. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 117
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7096

Financial Performance

In 2024, StemCell Institute's revenue was 2.68 billion, an increase of 7.98% compared to the previous year's 2.48 billion. Earnings were 385.00 million, an increase of 24.19%.